An organotypic model is helping researchers better understand disease processes in ulcerative colitis and colorectal cancer.
Universal screening for endometrial cancer, begun in 2012 at Cleveland Clinic, has helped build one of the largest prospective cohorts of screened patients, providing fertile ground for studying Lynch syndrome.
Cleveland Clinic colorectal surgeons Matthew Kalady, MD, and Steven Wexner, MD, explain what The National Accreditation Program for Rectal Cancer means to patients and clinicians.
An investigation of tumor biology presented at ASCRS 2018 clearly shows the relationship of age with disparate neoplastic pathways, and with left- vs. right-sided tumors.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Two Cleveland Clinic physicians played instrumental roles in the development of new standards for a multidisciplinary approach to rectal cancer care.
A new study reveals that 38 percent of young adults with polyps on colonoscopy have high-risk polyps. Carol Burke, MD, provides insight on improving patient care for young adults with polyps.
Cleveland Clinic surgeons used a new transplant protocol to treat a patient with liver metastases from colorectal cancer for the first time in the U.S. Learn how this protocol could improve patient outcomes.
A $2.6 million grant from the National Cancer Institute will aid work to understand how colorectal cancer develops and spreads.
Why is use of robot-assisted surgery for rectal cancer growing despite evidence it doesn’t offer significant advantages? Cleveland Clinic Florida Colorectal Chairman Steven Wexner, MD, discusses in our “Viewpoints” series.
Should colonoscopic tattooing be standard to improve the accuracy of intraoperative lesion localization? Cleveland Clinic Florida Colorectal Chairman Steven Wexner, MD, examines the evidence in our “Viewpoints” series.